Gyre Therapeutics Inc. (GYRE)
Gyre Therapeutics Max Pain By Strike
GYRE trades at $8.11, 62.2% above the near-term max pain of $5 expiring Aug 15, 2025 (-1 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$12.5), signaling increased put positioning or downside protection. Key magnetic zone at 3 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Gyre Therapeutics Max Pain By Expiry
Max pain for GYRE shows a downward trend from 12.5 to 2.5, indicating bearish sentiment or hedging activity. The 167% spread signals divergent expectations across timeframes. Most levels below 8.11 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 5 | -3.11 (-38.35%) |
| Sep 19, 2025 | 2.5 | -5.61 (-69.17%) |
| Oct 17, 2025 | 7.5 | -0.61 (-7.52%) |
| Jan 16, 2026 | 12.5 | 4.39 (54.13%) |
| Apr 17, 2026 | 2.5 | -5.61 (-69.17%) |